TIR decreases the glycated hemoglobin level in T2DM patients more efficiently than the GLP-1 RA semaglutide [14, 15], can significantly improve systemic insulin sensitivity [16], and is very effective in overcoming insulin resistance [17]. The gene discussed is GCG; the disease is type 2 diabetes mellitus.